Drug Interaction Report

Adalimumab Injection and Typhoid Vaccine, Live: Interaction Details

Name: Adalimumab Injection and Typhoid Vaccine, Live Interaction
Creator: Dr. Brian Staiger, PharmD, BCPS

A pharmacist-reviewed analysis of the Adalimumab Injection and Typhoid Vaccine, Live interaction: the documented clinical effects, severity rating, onset, mechanism, and management considerations, with cited references throughout.

AI-assisted, pharmacist-reviewed · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Adalimumab Injection

Abrilada Abrilada® (adalimumab-afzb) Amjevita Amjevita® (adalimumab-atto) Cyltezo Cyltezo® (adalimumab-adbm) Hadlima Hadlima® (adalimumab-bwwd)

Typhoid Vaccine, Live

Vivotif

Medically reviewed by

Dr. Brian Staiger, PharmD, BCPS

Updated Jul 10, 2026

Editorial policy · Data sources

Interaction severity

Major

Potentially serious — often needs a change or close monitoring.

Minor

Moderate

Major

Contraindicated

How we grade severity & evidence

Severity levels

Contraindicated: These should generally not be used together.
Major: Potentially serious — often needs a change or close monitoring.
Moderate: Can be significant — usually manageable with monitoring.
Minor: Usually limited clinical impact.

Evidence grades

Established: Well documented — supported by controlled studies or strong clinical data.
Probable: Good supporting evidence, though not definitively proven.
Suspected: Some evidence suggests this interaction, but it is not well established.
Possible: Limited or conflicting evidence; the interaction may occur.
Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 34 documented Adalimumab Injection interactions, 34 are rated major — including this one.

Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.

Onset

unspecified

Evidence

theoretical

Severity

Major

What happens

An increased risk of secondary transmission of infection by the live vaccine

Interaction Deep Dive

Avoid coadministration of live vaccines in patients receiving adalimumab or an adalimumab biosimilar product. There is no data on the secondary transmission of infection by live vaccines in patients receiving adalimumab or an adalimumab biosimilar product³¹².

Why it happens (mechanism)

Altered cellular immune response

Common questions

Can I take Adalimumab Injection and Typhoid Vaccine, Live together?

An increased risk of secondary transmission of infection by the live vaccine Always confirm with your pharmacist or prescriber before making any change.

How serious is the Adalimumab Injection and Typhoid Vaccine, Live interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

Does my dose of Adalimumab Injection or Typhoid Vaccine, Live need adjusting while I take them together?
What symptoms should prompt me to call you or my prescriber right away?
Does the timing of my doses matter for this combination?
Is there a safer alternative to one of these medications for me?

References (3)

Product Information: HUMIRA(R) subcutaneous injection, adalimumab subcutaneous injection. AbbVie Inc (per manufacturer), North Chicago, IL, 2016. DailyMed
Product Information: Yusimry(TM) subcutaneous injection, adalimumab-aqvh subcutaneous injection. Coherus BioSciences, Inc (per FDA), Redwood City, CA, 2023. DailyMed
Product Information: AMJEVITA® subcutaneous injection, adalimumab-atto subcutaneous injection. Amgen Inc (per FDA), Thousand Oaks, CA, 2025. DailyMed

Was this write-up helpful?

Adalimumab Injection

Keep reading about Adalimumab Injection

All Adalimumab Injection interactions (34) Adalimumab Injection drug information

Also serious with: Abatacept Adenovirus Vaccine Type 4, Live Adenovirus Vaccine Type 7, Live Anakinra

Typhoid Vaccine, Live

Keep reading about Typhoid Vaccine, Live

All Typhoid Vaccine, Live interactions (73)

Also serious with: Ocrelizumab Injection Anifrolumab-Fnia Injection Emapalumab-Lzsg Injection Canakinumab Injection

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

A message from HelloPharmacist

About our interaction database: depth, not breadth

HelloPharmacist doesn't license one of the big commercial interaction databases, so what you'll find here is not a complete list of every known drug interaction. Instead, each entry is researched, analyzed, and written up individually — documented from the published literature, reviewed by a pharmacist, and cited so you can check every source yourself.

If a combination isn't listed here, it means we haven't documented it yet — never that it's safe. For screening a full medication list, we recommend pairing this site with a comprehensive tool like the Drugs.com Interaction Checker and, most importantly, a review by your own pharmacist. For a deep, plain-English, fully sourced explanation of a specific documented interaction — that's exactly what we built this for.

This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.